Home » Prices » NASDAQ:AMGN

Amgen Inc. stock price

Today's NASDAQ:AMGN chart, history & news

Price:
227.16 USD
Change:
-0.82 (-0.36%)
Key Stats
Price open 228.72
Previous close 227.98
Market cap 133.05B
Volume 2.11M
Day high 230.07
Day low 226.3
Year high 264.97
Year low 177.05
Year to date change -5.75%
P/E Ratio 18.44
Company Profile
Fundamentals
Insider Information
News

About Amgen Inc.

Amgen Inc. is a drug manufacturing company incorporated in 1980. Venture capitalists William Bowes and others conceived the idea for Applied Molecular Genetics, Inc. with only three people as staff. In its first months of operation, AMGen Inc. received overwhelming support from investors and embarked on innovative genetic engineering. Subsequent success saw Amgen offer an IPO to list on NASDAQ in 1983. The stock trades under AMGN as its symbol. Since its founding, Amgen has its headquarters in Thousand Oaks, California.

Amgen is a major player in the global healthcare industry where it produces human therapeutics for users from across the globe. Some of the most popular products from Amgen include Enbrel, which treats arthritis and psoriasis; Neulasta, which targets cancer patients, and Prolia, which treats osteoporosis in postmenopausal women. The market for Amgen’s products includes healthcare facilities, physicians, pharmacies, and clinics. The company operates collaboratively with industry greats like Bayer HealthCare Pharmaceuticals Inc. and Novartis.

Company information

Company name
Amgen, Inc.
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
23,400
CEO
Robert A. Bradway
Address
One Amgen Center Drive, Thousand Oaks, CA, 91320-1799
Country
United States
Contact information
1.805.447.1000
Website
http://www.amgen.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.